[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350077-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350077-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mpn-fit-a-randomized-controlled-pilot-trial-of-supervised-exercise-in-myeloproliferative-neoplasms","MPN-FIT - a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms","","MPN-FIT evaluates a structured, home-based supervised exercise program for patients with myeloproliferative neoplasms (MPN), where high symptom burden and impaired quality of life persist despite limited curative options. In a randomized controlled pilot design (n=55), participants received 12 weeks of flexibility, resistance, and aerobics supervised by a kinesiologist versus waitlist control. Feasibility and acceptability were high, with strong intent to continue. Compared with controls, the FIT group showed a significant reduction in LDH and participants reported improvements in symptoms, alongside potential benefits on inflammatory and disease markers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mpn-fit-a-randomized-controlled-pilot-trial-of-supervised-exercise-in-myeloproliferative-neoplasms/350077/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mpn-fit-a-randomized-controlled-pilot-trial-of-supervised-exercise-in-myeloproliferative-neoplasms/350077.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the MPN-FIT trial?","Question",{"text":63,"@type":64},"To assess feasibility, acceptability, and efficacy of a supervised home-based exercise program for patients with MPN, including changes in symptom burden, quality of life, and clinical/inflammatory markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the trial designed and what did participants do?",{"text":68,"@type":64},"Patients with MPN (n=55) were randomized 3:2 to a 12-week supervised home exercise intervention (flexibility, resistance, aerobics) with a kinesiologist or a waitlist control.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes showed differences between the exercise group and controls?",{"text":72,"@type":64},"All feasibility benchmarks were met, and LDH decreased significantly in FIT patients compared with controls. Interviewed participants also described positive effects on symptoms and recommended the program.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350077,1790502042,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","REGULAR ARTICLE  \nMPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms  \nMarie Ouellet,1, 2 Angelo Rizzolo,3, 4 Caroline Venne,5 Hanane Moussa,6 Karine Bilodeau,7, 8 Luigina Mollica, 1, 2,6,8 Genevi`eve Chabot-Roy,8 Genevi`eve Huynh-Trudeau, 1, 2,8 Sylvie Lesage,8, 9 Michaël Harnois,6 Lambert Busque, 1, 2,6,8 Shireen Sirhan,3,4,6 and Natasha Szuber 1, 2,6,8  \n1 Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada; 2 Department of Medicine, University of Montreal, Montreal, Canada; 3 Segal Cancer Centre, Jewish General Hospital, Montreal, Canada; 4 Department of Medicine, McGill University, Montreal, Canada; 5 Quebec Kinesiologist Federation, Montreal, Canada;  \n6 Quebec CML-MPN Research Group, Montreal, Canada; 7 Faculty of Nursing, University of Montreal, Montreal, Canada; 8 Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada; and 9 D´epartement de microbiologie, infectiologie et immunologie, Universit´e de Montr´eal, Montreal, Canada  \nKey Points  \n• A structured, homebased exercise intervention in MPN was feasible, well accepted, and showed initial benefits on disease-related markers.  \n• Physical activity is a potentially safe and accessible adjunct to standard treatments in this population, warranting further study.  \nMyeloproliferative neoplasms (MPN) are associated with a high symptom burden and impaired quality of life (QoL), often unaided by available treatments. Physical activity has demonstrated benefits in other cancers; however, its potential has yet to be explored in MPN. This randomized controlled trial aimed to evaluate the feasibility, acceptability, and efficacy of a supervised exercise program for patients with MPN based on longitudinal assessment of symptom burden, QoL, and clinical/inflammatory markers (C-reactive protein, erythrocyte sedimentation rate, ferritin, lactate dehydrogenase [LDH], and serum cytokines) . Patients with MPN (n = 55) were randomized 3:2 to a 12-week home-based exercise intervention (flexibility/resistance/aerobics) supervised by a kinesiologist vs waitlist control. Measures included patient-reported outcome questionnaires, peripheral blood sampling, and postintervention interviews with participants. Forty-seven patients completed the trial (FIT group, n = 26; control group, n = 21) . Median age was 66 years (range, 27-86), and 60% were female. All feasibility benchmarks were met, with 88% of participants satisfied and 92% with intent to continue an exercise program on a regular basis. A significant reduction in LDH was observed in FIT patients compared with controls (−14.5 U/L vs +4.0 U/L; P = .03) . Patients interviewed described positive effects of the intervention on symptoms and would unanimously recommend the program to others with MPN. In this pilot study, supervised exercise was feasible, acceptable, and showed potential benefits on inflammatory/disease markers.  \nIntroduction  \nMyeloproliferative neoplasms (MPN), including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF), are chronic blood cancers associated with a high symptom burden.1-3 With no definitive pharmacological cure and stem cell transplant being an option for only a minority of cases, patients face lifelong symptoms that lead to psychological distress and impaired quality of life (QoL) .4,5 Available pharmacological agents, including Janus kinase inhibitors, provide partial symptom  \nSubmitted 8 October 2025; accepted 19 November 2025; prepublished online on Blood Advances First Edition 7 January 2026. [https://doi.org/10.1182/](https://doi.org/10.1182/)[ ](https://doi.org/10.1182/)[bloodadvances.2025018682](bloodadvances.2025018682.)[.](bloodadvances.2025018682.)  \nData are available from the corresponding author, Natasha Szuber (natasha.szuber@ [umontreal.ca](umontreal.ca)), on request. Individual participant data will not be shared.  \nThe full-text version of this article contains a data supplement. ","cbCaihB94E4KzStr","https://ap.wps.com/l/cbCaihB94E4KzStr","pdf",780042,11,"English","# Key Points\n# Introduction","[{\"question\":\"What is the main purpose of the MPN-FIT trial?\",\"answer\":\"To assess feasibility, acceptability, and efficacy of a supervised home-based exercise program for patients with MPN, including changes in symptom burden, quality of life, and clinical/inflammatory markers.\"},{\"question\":\"How was the trial designed and what did participants do?\",\"answer\":\"Patients with MPN (n=55) were randomized 3:2 to a 12-week supervised home exercise intervention (flexibility, resistance, aerobics) with a kinesiologist or a waitlist control.\"},{\"question\":\"What outcomes showed differences between the exercise group and controls?\",\"answer\":\"All feasibility benchmarks were met, and LDH decreased significantly in FIT patients compared with controls. Interviewed participants also described positive effects on symptoms and recommended the program.\"}]","MPN-FIT - a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms | PDF",1790087038,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3799e84a1026e445c6136e5d026cc563.webp",983,1296,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b53983f34ceba1bd4d98ab68a4053d3.webp",982,1294,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b04a4978de7e4318ffffea7914f55ea.webp",981,1293,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c012dbb67b4189ce107f1d10f8778da6.webp",980,1292]